metaMe Health provides proven non-drug treatment to patients suffering from GI disorders such as IBS and functional heartburn by connecting them to our network of state-licensed therapists. All of our therapists are specially trained in GI health. Treatment sessions are held on our secure metaMe Connect online platform (www.metameconnect.com). metaMe Connect is available directly to consumers and through self-insured employers and other payers.
We connect patients with proven treatment
Brain-Gut therapy is form of cognitive therapy used to address GI pain and discomfort, which results in reduced use of medications and reduced illness-related work absences. metaMe Health holds worldwide exclusive license for online use of the only standardized, clinically proven Brain-Gut treatment protocol. Brain-Gut therapy is the most effective treatment for IBS, but primary care and GI practice groups do not have therapists on staff and do not know where to send patients for treatment. In addition, there are geographic barriers to treatment because of the scarcity of licensed providers trained in Gut health. We address both problems by providing clinically-proven treatment and licensed providers online. Therapists benefit earning extra income and working on their own schedule. For our enterprise customers and individual patients, metaMe Connect reduces healthcare costs reducing doctor visits, reducing medication prescriptions and reducing high-end referrals to GI specialists.
Scientific Advisory Board
metaMe Health has assembled leaders in the field of GI health to advise us on scientific issues surrounding Brain-Gut Therapy.
Dr. Laurie Keefer, PhD
Dr. Keefer is a GI Health Psychologist and the Director of Psychobehavioral Research at the Ichan School of Medicine at Mount Sinai in New York City. She has been a pioneer in the development of effective behavioral therapies for the full range of gastrointestinal disorders, including IBS, Crohn’s Disease, ulcerative colitis, reflux disease and other esophageal disorders. Previously, she was Associate Professor at the Northwestern University Feinberg School of Medicine in Chicago, where she retains an Adjunct appointment. She is licensed in both Illinois and New York.
Dr. Olafur Palsson, PsyD
Dr. Palsson is a clinical psychologist and health researcher with a long-standing interest in the relationship between mind and body in the determination of health and illness. He is originally from Iceland. Dr. Palsson's current research interests include investigation of the psychological and physiological aspects of gastrointestinal disorders and symptoms, development of questionnaires to improve GI research, and the use of psychological treatments for IBS and other functional GI disorders.
Dr. John Pandolfino, MD
Dr. Pandolfino is the Chief of Gastroenterology and Hepatology in the Department of Medicine at Northwestern Medicine. He is also the Hans Popper Professor of Medicine.
A major aim Dr. Pandolfino’s current research focuses on improving diagnosis and management of GERD patients not responding to proton pump inhibitor (PPI) therapy. This group of patients represents a significant burden as up to 30-50% of all GERD patients are not satisfied with their response to PPI therapy. Additional information about Dr. Pandolfino can be found here.
Clinical Advisory Board
In addition to our Scientific Advisory Board, metaMe Health has recruited leading GI physicians and providers to advise us on clinical matters.
Dr. Darren Brenner, MD
-Associate Professor of Medicine (Gastroenterology and Hepatology) and Surgery
-Associate Professor of Surgery
Additional information about Dr. Brenner can be found here.
Dr. Sarah Kinsinger, PhD
-Associate Professor of Medicine & Psychiatry
-Board Certified Clinical Health -Psychology by the American Board of Professional Psychology
-Director, Behavioral Medicine for Digestive Health Program
-Division of Gastroenterology & Nutrition
-Loyola University Medical Center
Additional information about Dr. Kinsinger can be found here.
Dr. Stephen Hanauer, MD
-Clifford Joseph Barborka Professor
-Professor of Medicine (Gastroenterology and Hepatology)
Dr. Hanauer joined Northwestern Medicine in January 2014 as the Clifford Joseph Barborka Professor of Medicine and the medical director of the Digestive Disease Center.He serves as chair of the International Organization for Inflammatory Bowel Disease, secretary-elect of the American College of Gastroenterology, and is a member of the GI Specialty Board of Internal Medicine, the American College of Physicians, and American Gastroenterology Association. He previously served as chair of the Food and Drug Administration (FDA) Gastrointestinal Drugs Advisory Committee, where he authored the FDA’s “Guidelines for Clinical Evaluation of Drugs for Patients with Inflammatory Bowel Disease.”
Additional information about Dr. Hanauer can be found here.